CoChat

Procoagulant and immunogenic properties of melanoma exosomes, microvesicles and apoptotic vesicles

Open access
Muhsin-Sharafaldine, Morad-Rémy, Saunderson, Sarah C., Dunn, Amy C., Faed, James M., Kleffmann, Torsten, McLellan, Alexander D. · 2016 · Oncotarget
Cited by 125

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

// Morad-Rémy Muhsin-Sharafaldine 1 , Sarah C. Saunderson 1 , Amy C. Dunn 1 , James M. Faed 2 , Torsten Kleffmann 3 , Alexander D. McLellan 1, 4 1 Department of Microbiology and Immunology, University of Otago, Dunedin, Otago, New Zealand 2 Department of Pathology, University of Otago, Dunedin, Otago, New Zealand 3 Centre for Protein Research, University of Otago, Dunedin, Otago, New Zealand 4 Department of Microbiology and Immunology, Otago School of Medical Sciences, University of Otago, Dunedin, Otago, New Zealand Correspondence to: Alexander D. McLellan, email: alex.mclellan@otago.ac.nz Keywords: tumor vesicles, apoptotic vesicles, coagulation, tissue factor, cancer immunity Received: April 06, 2016 Accepted: June 17, 2016 Published: July 22, 2016 ABSTRACT Extracellular vesicles (EV) are lipid particles released from eukaryotic cells into the extracellular fluid. Depending on the cell type or mechanism of release, vesicles vary in form and function and exert distinct functions in coagulation and immunity. Tumor cells may constitutively shed vesicles known as exosomes or microvesicles (MV). Alternatively, apoptosis induces the release of apoptotic blebs or vesicles (ApoV) from the plasma membrane. EV have been implicated in thrombotic events (the second highest cause of death in cancer patients) and tumor vesicles contribute to the anti-cancer immune response. In this study, we utilized the well characterized B16 melanoma model to determine the molecular composition and procoagulant and immunogenic potential of exosomes, MV and ApoV. Distinct patterns of surface and cytoplasmic molecules (tetraspanins, integrins, heat shock proteins and histones) were expressed between the vesicle types. Moreover, in vitro coagulation assays revealed that membrane-derived vesicles, namely MV and ApoV, were more procoagulant than exosomes–with tissue factor and phosphatidylserine critical for procoagulant activity. Mice immunized with antigen-pulsed ApoV and challenged with B16 tumors were protected out to 60 days, while lower protection rates were afforded by MV and exosomes. Together the results demonstrate distinct phenotypic and functional differences between vesicle types, with important procoagulant and immunogenic functions emerging for membrane-derived MV and ApoV versus endosome-derived exosomes. This study highlights the potential of EV to contribute to the prothrombotic state, as well as to anti-cancer immunity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.10783

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 60

  1. Buzas, 2011, Membrane vesicles current state-of-the-art: emerging role of extracellular vesicles, Cell Mol Life Sci, 68, 2667, 10.1007/s00018-011-0689-3 · DOI · Paper page
  2. Segura, 2009, Membrane vesicles as conveyors of immune responses, Nat Rev Immunol, 9, 581, 10.1038/nri2567 · DOI · Paper page
  3. Bonnerot, 2005, Exosomal-like vesicles are present in human blood plasma, Int Immunol, 17, 879, 10.1093/intimm/dxh267 · DOI · Paper page
  4. McLellan, 2006, Circulating soluble forms of major histocompatibility complex antigens are not exosome-associated, Eur J Immunol, 36, 2875, 10.1002/eji.200636041 · DOI
  5. Sverdlov, 2012, Amedeo Avogadro's cry: what is 1 microg of exosomes?, Bioessays, 34, 873, 10.1002/bies.201200045 · DOI · Paper page
  6. Osanto, 2013, Cryo-electron microscopy of extracellular vesicles in fresh plasma, J Extracell Vesicles, 2
  7. Mackman, 2013, Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients, Blood, 122, 1873, 10.1182/blood-2013-04-460139 · DOI · Paper page
  8. Amigorena, 2001, Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles, J Immunol, 166, 7309, 10.4049/jimmunol.166.12.7309 · DOI · Paper page
  9. Schett, 2012, Macrophages discriminate glycosylation patterns of apoptotic cell-derived microparticles, J Biol Chem, 287, 496, 10.1074/jbc.M111.273144 · DOI
  10. McLellan, 2016, The CD169 sialoadhesin molecule mediates cytotoxic T-cell responses to tumour apoptotic vesicles, Immunol Cell Biol, 94, 430, 10.1038/icb.2015.111 · DOI
  11. Rosen, 1994, Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes, J Exp Med, 179, 1317, 10.1084/jem.179.4.1317 · DOI · Paper page
  12. Grinstein, 2010, The distribution and function of phosphatidylserine in cellular membranes, Annual review of biophysics, 39, 407, 10.1146/annurev.biophys.093008.131234 · DOI · Paper page
  13. Hallett, 2004, Adhesion and signaling by B cell-derived exosomes: the role of integrins, Faseb J, 18, 977, 10.1096/fj.03-1094fje · DOI · Paper page
  14. McLellan, 2008, Induction of exosome release in primary B cells stimulated via CD40 and the IL-4 receptor, J Immunol, 180, 8146, 10.4049/jimmunol.180.12.8146 · DOI · Paper page
  15. Rak, 2008, Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells, Nature cell biology, 10, 619, 10.1038/ncb1725 · DOI · Paper page
  16. Francis, 2008, Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation, J Thromb Haemost, 6, 1517, 10.1111/j.1538-7836.2008.02987.x · DOI · Paper page
  17. Wickline, 2011, Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis, Cancer Res, 71, 3792, 10.1158/0008-5472.CAN-10-4455 · DOI · Paper page
  18. Madden, 2011, Pancreatic cancer cell and microparticle procoagulant surface characterization: involvement of membrane-expressed tissue factor phosphatidylserine and phosphatidylethanolamine, Blood coagulation & fibrinolysis, 22, 680, 10.1097/MBC.0b013e32834ad7bc · doi:10.1097/mbc.0b013e32834ad7bc
  19. Olson, 2012, How apoptotic cells aid in the removal of their own cold dead bodies, Cell Death Differ, 19, 735, 10.1038/cdd.2012.25 · DOI · Paper page
  20. Basbaum, 2004, The microvesicle as a vehicle for EMMPRIN in tumor-stromal interactions, Oncogene, 23, 956, 10.1038/sj.onc.1207070 · DOI · Paper page
  21. Jelinek, 2014, Multiple myeloma dell-derived microvesicles are enriched in CD147 expression and enhance tumor cell proliferation, Oncotarget, 5, 5686, 10.18632/oncotarget.3667 · DOI
  22. Clayton, 2010, Proteomics analysis of bladder cancer exosomes, Mol Cell Proteomics, 9, 1324, 10.1074/mcp.M000063-MCP201 · DOI · Paper page
  23. Adema, 2011, Antigen localization controls T cell-mediated tumor immunity, J Immunol, 187, 1281, 10.4049/jimmunol.1003905 · DOI
  24. Arancia, 2002, Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles, The Journal of experimental medicine, 195, 1303, 10.1084/jem.20011624 · DOI · Paper page
  25. Amigorena, 1998, Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes, Nature medicine, 4, 594, 10.1038/nm0598-594 · DOI · Paper page
  26. Rak, 2010, Microparticles in cancer, Seminars in thrombosis and hemostasis, 36, 888, 10.1055/s-0030-1267043 · DOI · Paper page
  27. Wickline, 2011, Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis, Cancer research, 71, 3792, 10.1158/0008-5472.CAN-10-4455 · DOI · Paper page
  28. Osanto, 2007, Microparticle-associated tissue factor activity: a link between cancer and thrombosis?, Journal of thrombosis and haemostasis, 5, 520, 10.1111/j.1538-7836.2007.02369.x · DOI · Paper page
  29. Pawlinski, 2012, Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer, Blood, 119, 5543, 10.1182/blood-2012-01-402156 · DOI · Paper page
  30. Francis, 2008, Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation, Journal of thrombosis and haemostasis, 6, 1517, 10.1111/j.1538-7836.2008.02987.x · DOI · Paper page
  31. Lyman, 2007, Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy, Journal of Thrombosis and Haemostasis, 5, 632, 10.1111/j.1538-7836.2007.02374.x · DOI · Paper page
  32. Taubman, 2008, Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer, Journal of Thrombosis and Haemostasis, 6, 1983, 10.1111/j.1538-7836.2008.03156.x · DOI · Paper page
  33. Weltermann, 2008, Chemotherapy-induced thrombosis: a role for microparticles and tissue factor?, Seminars in thrombosis and hemostasis, 34, 199, 10.1055/s-2008-1079261 · doi:10.1055/s-2008-1079261
  34. McLellan, 2014, CD169 mediates the capture of exosomes in spleen and lymph node, Blood, 123, 208, 10.1182/blood-2013-03-489732 · DOI · Paper page
  35. McLellan, 2014, NK cells are required for dendritic cell-based immunotherapy at the time of tumor challenge, J Immunol, 192, 2514, 10.4049/jimmunol.1202797 · DOI
  36. McLellan, 2010, A defined serum-free medium useful for monitoring anti-melanoma responses induced by dendritic cell immunotherapy, J Immunol Methods, 352, 178, 10.1016/j.jim.2009.11.001 · doi:10.1016/j.jim.2009.11.001
  37. Barcinski, 2009, Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner, Cancer Lett, 283, 168, 10.1016/j.canlet.2009.03.041 · DOI · Paper page
  38. Reisfeld, 2010, Mouse models for melanoma: a personal perspective, Exp Dermatol, 19, 157, 10.1111/j.1600-0625.2009.00986.x · DOI
  39. Vader, 2016, Cells release subpopulations of exosomes with distinct molecular and biological properties, Sci Rep, 6, 22519, 10.1038/srep22519 · DOI · Paper page
  40. Olson, 2013, Blebs produced by actin-myosin contraction during apoptosis release damage-associated molecular pattern proteins before secondary necrosis occurs, Cell Death Differ, 20, 1293, 10.1038/cdd.2013.69 · DOI · Paper page
  41. Nieto, 2015, Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines, Pigment Cell Melanoma Res, 28, 464, 10.1111/pcmr.12380 · DOI
  42. Zhang, 2013, Histone chaperones in nucleosome assembly and human disease, Nat Struct Mol Biol, 20, 14, 10.1038/nsmb.2461 · DOI · Paper page
  43. Duelli, 2012, MicroRNAs are exported from malignant cells in customized particles, Nucleic Acids Res, 40, 9125, 10.1093/nar/gks656 · DOI · Paper page
  44. Wied, 2012, Release of exosomes and microvesicles harbouring specific RNAs and glycosylphosphatidylinositol-anchored proteins from rat and human adipocytes is controlled by histone methylation, American Journal of Molecular Biology, 2, 187, 10.4236/ajmb.2012.23020 · DOI
  45. Mann, 1996, Blood clotting in minimally altered whole blood, Blood, 88, 3432, 10.1182/blood.V88.9.3432.bloodjournal8893432 · DOI · Paper page
  46. Esmon, 2011, Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4, Blood, 118, 1952, 10.1182/blood-2011-03-343061 · DOI · Paper page
  47. Abgrall, 2008, Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma, Thromb Haemost, 99, 767, 10.1160/TH07-09-0581 · DOI
  48. Neeves, 2014, Thrombin generation and fibrin formation under flow on biomimetic tissue factor-rich surfaces, J Thromb Haemost, 12, 373, 10.1111/jth.12491 · doi:10.1111/jth.12491
  49. Diamond, 2008, Determination of surface tissue factor thresholds that trigger coagulation at venous and arterial shear rates: amplification of 100 fM circulating tissue factor requires flow, Blood, 111, 3507, 10.1182/blood-2007-08-106229 · DOI
  50. Monteiro, 2009, Simultaneous tissue factor expression and phosphatidylserine exposure account for the highly procoagulant pattern of melanoma cell lines, Melanoma Res, 19, 301, 10.1097/CMR.0b013e32832e40fe · doi:10.1097/cmr.0b013e32832e40fe
  51. van der Meijden, 2014, Differential roles of tissue factor and phosphatidylserine in activation of coagulation, Thromb Res, 133, S54, 10.1016/j.thromres.2014.03.022 · DOI
  52. Lorenz, 2013, During apoptosis HMGB1 is translocated into apoptotic cell-derived membranous vesicles, Autoimmunity, 46, 342, 10.3109/08916934.2012.750302 · DOI
  53. Zitvogel, 2008, Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies, Cancer Res, 68, 4026, 10.1158/0008-5472.CAN-08-0427 · DOI · Paper page
  54. Janoff, 1990, Phospholipid in the hexagonal II phase is immunogenic: evidence for immunorecognition of nonbilayer lipid phases, Proc Natl Acad Sci U S A, 87, 4112, 10.1073/pnas.87.11.4112 · DOI
  55. Amigorena, 1998, Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes, Nat Med, 4, 594, 10.1038/nm0598-594 · DOI · Paper page
  56. Gabrielsson, 2013, Dendritic cell-derived exosomes need to activate both T and B cells to induce antitumor immunity, J Immunol, 190, 2712, 10.4049/jimmunol.1203082 · DOI · Paper page
  57. Lord, 2001, Tumours can act as adjuvants for humoral immunity, Immunology, 102, 486, 10.1046/j.1365-2567.2001.01213.x · DOI
  58. Ham, 2009, Spin filter-based sample preparation for shotgun proteomics, Nat Methods, 6, 785
  59. Mechtler, 2014, MS Amanda a universal identification algorithm optimized for high accuracy tandem mass spectra, J Proteome Res, 13, 3679, 10.1021/pr500202e · DOI · Paper page
  60. McLellan, 2011, Effects of early atipamezole reversal of medetomidine-ketamine anesthesia in mice, J Am Assoc Lab Anim Sci, 50, 916

Cited by

See all 125

Metadata

Authors
Muhsin-Sharafaldine, M.-R., Saunderson, S. C., Dunn, A. C., Faed, J. M., Kleffmann, T., & McLellan, A. D.
Venue
Oncotarget
Published
2016-07-22
Volume
7
Issue
35
Pages
56279-56294
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2485668101
Cited by
125
References
10
FWCI
6.62
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Procoagulant and immunogenic properties of melanoma exosomes, microvesicles and apoptotic vesicles. https://app.cochat.ai/papers/10.18632/oncotarget.10783
The paper
Muhsin-Sharafaldine, M.-R., Saunderson, S. C., Dunn, A. C., Faed, J. M., Kleffmann, T., & McLellan, A. D. (2016). Procoagulant and immunogenic properties of melanoma exosomes, microvesicles and apoptotic vesicles. Oncotarget. https://doi.org/10.18632/oncotarget.10783

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.